Amazon expands telehealth presence, offers primary care for $9 a month

Online retail giant Amazon is expanding its foothold in the telemedicine space, offering members who pay for its Prime service access to virtual care visits with a healthcare provider. 

In announcing the plan, Amazon says televisits will cost $9 a month or $99 per year and will include the option to schedule in-person visits. All services are made possible through the national primary care organization One Medical, which Amazon acquired for $3.9 billion in February.

Televisits are covered by the subscription fee. However, while patients can schedule in-person visits at a One Medical location through Amazon, they will still have to cover the costs themselves or by having third-party insurance coverage.

The move to connect its Prime members to providers is the latest in a series of moves Amazon has made into healthcare. Others include a discount pharmacy service to compete with the likes of CVS, Walgreens and Walmart. 

“Prime members also have exclusive access to benefits from Amazon Pharmacy, including RxPass, which lets members get as many eligible medications as they need for one flat fee of $5 per month and have them delivered free to their doors in two days or less, and Prime Rx, which helps members save up to 80% on prescriptions when not using insurance at Amazon Pharmacy and over 60,000 pharmacies nationwide,” Jamil Ghani, vice president of Amazon Prime adds in the announcement.  

One Medical has more than 200 medical offices in 20-plus markets. The healthcare organization was known for its own (more expensive) subscription service, which acted as de facto insurance coverage for primary care visits, both remote and in-person. Its members now must go through Amazon to maintain their benefits, according to One Medical’s website

The virtual care services offered through the Amazon partnership include 24/7 access to a provider as well as simplified prescription renewals. Members can access services on most mobile devices through the One Medical app.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.